Małgorzata Ż. G.
- Country
- Poland
- Department
- CenterMed Bandrowskiego
Research Overview
- A Phase 2b Dose-Ranging Study of Oral KT-621 in Adults with Uncontrolled Moderate to Severe Eosinophilic Asthma
- A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study of Subcutaneous PF‑07275315 in Adults with Moderate‑to‑Severe Chronic Obstructive Pulmonary Disease
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of Tezepelumab in Pediatric Patients Aged 5 to <12 Years with Severe Uncontrolled Asthma
Data & Insights
Has run more than one trial at 78 of 367 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating severe uncontrolled asthma across different age groups, with particular expertise in managing respiratory conditions that require advanced therapeutic interventions.
- Adult severe asthma management
- Pediatric asthma care
- Combination inhaler therapies
Their work encompasses evaluation of novel treatment approaches for patients whose asthma remains inadequately controlled with standard therapies.
Allergic Disorders
The investigator demonstrates significant involvement in treating allergic respiratory conditions, particularly focusing on seasonal allergic responses and their management.
- Seasonal allergic rhinitis
- Rhinoconjunctivitis treatment
- Immunotherapy approaches
Their expertise includes evaluation of targeted treatments for pollen-induced allergic conditions.
Specialized Therapeutic Areas
The investigator focuses on eosinophilic asthma and other inflammatory respiratory conditions, with particular attention to biological therapies and novel therapeutic agents.
- Biological therapy applications
- Inflammatory pathway targeting
- Advanced therapeutic monitoring
Their work includes evaluation of innovative treatments for patients with specific inflammatory markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.